SAN DIEGO -- Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in patients with hemoglobin SC, a milder form of sickle cell disease (SCD), a ...

New Delhi [India], March 18 (ANI): The pharmaceutical manufacturer Akums Drugs and Pharmaceuticals Limited has announced India's first homegrown indigenous Hydroxyurea oral suspension for the ...

Background: The Multicenter Study of Hydroxyurea (HU) in Sickle Cell Anemia (MSH) previously showed that daily oral HU reduces painful sickle cell (SS) crises by 50% in patients with moderate to ...

Recent research highlights the significant underuse of disease-modifying therapies for sickle cell disease, despite their ...

Hydroxyurea is an antineoplastic agent, prescribed for sickle cell anemia, several types of cancer (such as melanoma, chronic myelogenous leukemia, squamous cell carcinomas), as an adjunct to ...

Researchers studied the efficacy of hydroxyurea at reducing stroke risk in sickle cell anemia, the most common and severe ...

Hydroxyurea Significantly Reduces Infections in Children With Sickle Cell Anemia Jan. 29, 2024 — Researchers have revealed that hydroxyurea significantly reduces infections in children with ...

Discover all the brand names or Trade names of generic drug called Hydroxyurea. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to ...